Objective: Lateral epicondylitis is a common complaint, with an annual incidence Abstract between 1% and 3% in the general population. The Dutch College of General Practitioners in The Netherlands has issued guidelines that recommend a waitand-see policy. However, these guidelines are not evidence based. Design and setting: This paper presents the results of an economic evaluation in conjunction with a randomised controlled trial to evaluate the effects of three interventions in primary care for patients with lateral epicondylitis.
versus corticosteroid injections, and €34 500 for physiotherapy versus the waitand-see policy.
Conclusions:
The results of this economic evaluation provided no reason to update or amend the Dutch guidelines for GPs, which recommend a wait-and-see policy for patients with lateral epicondylitis.
Lateral epicondylitis (tennis elbow) is a common patients with lateral epicondylitis. An evaluation of the clinical effects of this trial has been reported complaint. In general, it is self-limiting and has a elsewhere. [11] rather benign character. It is considered to be an overload injury, typically following a minor and Patients and Methods often unrecognised trauma. The annual incidence is between 1% and 3% in the general population, [1, 2] and in general practice the incidence of lateral
Study Population
epicondylitis is estimated at 4-7 per 1000 patients Patients were recruited by 85 GPs in two cities in per year. [3] The average duration of a typical episode The Netherlands from September 1997 to October is reported to be between 6 months and 2 years. [4, 5] 1998. The patients were included in the trial if they In primary care, patients with lateral epicon-met the following criteria: (i) pain at the lateral side dylitis are often treated with corticosteroid injec-of the elbow for at least 6 weeks; (ii) pain increasing tions or physiotherapy. [2, 3] Review articles, how-with pressure on the lateral epicondyl and during ever, demonstrate that the currently published ran-resisted dorsiflexion; (iii) age between 18 and 70 domised controlled trials present conflicting years; (iv) willingness to comply with treatment and results. [6, 7] Considering the lack of scientific support follow-up measurements; and (v) written informed for the effectiveness of active interventions and the consent. relatively benign course of lateral epicondylitis, the Patients were excluded from the trial if they had: Dutch College of General Practitioners issued (i) received physiotherapy or corticosteroid injecguidelines in 1997 that recommended a wait-andtions for lateral epicondylitis in the previous 6 see policy, with the prescription of pain medication months; (ii) bilateral elbow symptoms; (iii) surgery if necessary. [8] This approach is already considered of the elbow; (iv) contraindications for corticosterto be common practice in many countries and setoid injections; or (v) if there was evidence of any tings.
specific pathology (e.g. malignancy, fracture or inAs yet, no studies have investigated the cost flammation). effectiveness of commonly used treatments for lateral epicondylitis. Insight into the cost effectiveness Interventions of various healthcare interventions can be used to After inclusion and baseline measurements, pasupport decision making to determine the allocation tients were randomly assigned to 6 weeks of physioof scarce resources and to achieve maximum health therapy, corticosteroid injections or a wait-and-see outcomes (prevent sick leave and disability). Cost policy. [11] All co-interventions were discouraged, effectiveness can be assessed in an economic evalubut patients were allowed to get prescriptions of ation that compares both the costs and the effectivepain medication if necessary. ness of two or more alternatives. [9, 10] 
Corticosteroid Injections
Therefore, an economic evaluation was conducted alongside a randomised controlled trial to evaluPatients were given a single local corticosteroid ate the cost effectiveness of corticosteroid injec-injection of 1mL triamcinolone (10 mg/mL) and tions, physiotherapy and a wait-and-see policy for 1mL lidocaine 2% on up to three separate occasions.
The patient was injected until free of pain, with a Economic Evaluation maximum of 2mL per injection.
The aim of the economic evaluation was to deterPhysiotherapy mine and compare the total costs related to elbow Physiotherapy consisted of treatment with pulsed complaints for patients receiving corticosteroid inultrasound (2 W/cm 2 , applied for 7.5 minutes), deep jections, physiotherapy and a wait-and-see policy, friction massage and an exercise program, over a and to relate these costs to the effects. period of 6 weeks. [12] Treatment sessions of approxiFirstly, relevant categories of resource utilisation mately 30 minutes were scheduled twice a week, were identified. Secondly, the volume of each catewith a maximum of nine treatment sessions.
gory for each individual patient was measured, and these volumes were multiplied by the resource costs.
Wait-and-See Policy
A societal viewpoint was used as the basis for the Patients visited their GP once during the 6-week economic evaluation. Direct healthcare costs, direct intervention period. During this visit, the GP disnon-healthcare costs and indirect costs due to lateral cussed with the patient any activities that caused epicondylitis were used as economic indicators. over-the-counter medication), costs of paid and unto 'completely recovered'. Success was defined as paid help. Indirect costs of loss of production due to 'much improved' or 'completely recovered'. The tennis elbow-related absence from work, or days of patients rated their pain during the day, in the week inactivity, were also included. All costs are given in preceding their periodic assessment, on an 11-point 1999 values. numerical scale (0 indicating no pain). Elbow disaThe number of treatment sessions for physiotherbility was measured by means of the modified Pain apy, the number of visits to the GP and the number Free Function Questionnaire. [13] This questionnaire of injections during the intervention period were consists of common situations that might cause elrecorded by the healthcare providers on standarbow pain (0 indicating no pain). All outcome values dised forms. Data regarding the use of other healthfor the pain scale and the modified Pain Free Funccare resources were assessed by means of five cost tion Questionnaire were transformed into a 100-diaries per patient for the entire follow-up period of point scale to facilitate interpretation and allow 52 weeks. [17] These diaries were completed by the comparison across outcome measures. QOL was patients and returned to the research assistant at the measured with the EuroQol, [14, 15] and expressed as research centre. utility values ranging from 0 to 1, where 1 represents perfect health. [16] The direct healthcare and direct non-healthcare Outcome measures were assessed by means of costs (table I) were estimated according to recently self-reported patient questionnaires at baseline and published Dutch guidelines for cost analysis in 3, 6, 12, 26 and 52 weeks after randomisation. healthcare research. [18, 19] For cases to which these Patients visited the research centre on these occa-guidelines did not apply, the tariffs of the Dutch sions, and during the visit completeness of the ques-Central Organisation for Health Care Charges [20] tionnaires was checked.
were used to estimate costs. Visits to other health-according to the friction cost approach, based on a mean income of the Dutch population according to age and gender for employees. [22] [23] [24] The basic concept of the friction cost approach is that the amount of production lost (and/or the costs of maintaining production) because of sick leave depends on the time span needed to restore the initial level of production and costs. Sick employees can be replaced after a necessary period of adaptation, the so-called friction period, which was estimated to be 122 days in The Netherlands.
[18] For unpaid labour (e.g. voluntary work or household work), the indirect costs were estimated using a shadow price of €7.94 per hour.
[18]
Statistical Analysis
The economic evaluation was carried out according to the intention-to-treat principle. The patients remained in the group to which they were allocated at baseline. The primary clinical outcomes of the trial, i.e. general improvement, pain during the day and elbow disability, were included in the costeffectiveness analysis. A cost-utility analysis was also performed, in which the effects were expressed as utilities (based on the EuroQol). Because the c Prices according to the Dutch Association for acupuncture and Dutch Association for chiropractice.
d For paid labour, these costs were calculated using a valuation of the friction period for employees according to age and gender. [18] percentage of missing data was less than 5%, missing cost estimates were substituted by the mean of care professionals, acupuncturist or homeopath were the measured estimates from the intervention group estimated on the basis of fees or prices charged by in the relevant follow-up period. the professional organisations. The costs of medBootstrapping (2000 replications) was used for ication were estimated on the basis of prices charged pair-wise comparison of the mean costs between by the Royal Dutch Society for Pharmacy.
[21] To wait-and-see and injection, wait-and-see and physicalculate travel expenses, the mean distance from a otherapy, and physiotherapy and injection groups. patient's home to a practitioner was estimated. The On each set of bootstrap replications Tukey's post time spent by a patient when visiting a practitioner hoc test was performed. 95% confidence intervals was also included in the cost calculations, for which for the mean differences in costs were obtained by a shadow price of €7.94 per hour was used. [18] Only bias corrected and accelerated (BCa) bootstrapone patient underwent a diagnostic procedure (an x-ping. [25] The cost-effectiveness and cost-utility raray) so the tariff of the Dutch Central Organisation tios were also calculated with bootstrapping (5000 for Health Care Charges was used just for this replications), according to the bias corrected percenspecific procedure.
tile method using the primary outcome measures Indirect costs of loss of production due to tennis (in-house developed software to perform these calelbow, for both paid and unpaid labour, were calcu-culations is obtainable as shareware at http:// lated. For paid labour, these costs were calculated www.simtel.net/product.php?id=71029). [26] The effects were expressed as mean differences
Clinical Effects within each intervention group between baseline
The success rate in the physiotherapy group and 52 weeks. The bootstrapped cost-effect pairs (91%) was significantly higher compared with that were graphically represented on a cost-effectiveness in the injection group (69%) but not compared with plane. Acceptability curves were calculated, which that in the wait-and-see group (83%) after 52 weeks. show the probability that a treatment is cost effec-The difference in success rates between the waittive at a specific ceiling ratio. [27, 28] Efficient frontiers and-see policy and injections was not statistically were drawn in which the slope of this frontier re-significant. General improvement after 52 weeks on flects incremental cost effectiveness, i.e. the addi-the ordinal scale was: physiotherapy 0.90; wait-andtional cost at which an additional unit of effects can see policy 0.83; and corticosteroid injections 0.71. be purchased.
For pain during the day, the mean (95% CI) differences in improvement were -4 (-13 to +6) for injection versus wait-and-see, 7 (-2 to +17) for Results physiotherapy versus wait-and-see, and -11 (-20 to -2) for injection versus physiotherapy after 52 A total of 185 patients were included in the trial, weeks. For elbow disability, the mean (95% CI) and were randomised to corticosteroid injections (n differences in improvement were -8 (-16 to +1) for = 62), physiotherapy (n = 64) or a wait-and-see injection versus wait-and-see, 5 (-3 to +13) for policy (n = 59). Only two patients dropped out, both physiotherapy versus wait-and-see, and -13 (-20 to of whom were in the injection group. One hundred -5) for injection versus physiotherapy after 52 and eighty-three patients (99%) completed the weeks. These differences were statistically signif-1-year follow-up measurement.
icant in favour of physiotherapy compared with injections, but not for physiotherapy versus the waitEvery patient had to fill in five cost diaries, and-see policy or injections versus the wait-and-see covering the entire 52-week follow-up period, policy (table II) .
[11]
which resulted in a maximum total of 925 cost There were no significant differences between diaries. Only 14 cost diaries were not returned; the the groups with regards to utility. research assistant spent a considerable amount of time and effort in collecting these cost diaries, ac-
Utilisation of Healthcare Resources
counting for the small number of missing diaries. Complete cost data were available for 55 (93%) Table III presents data on the utilisation of the patients in the wait-and-see group, 58 (94%) in the main healthcare resources for lateral epicondylitis in injection group, and 60 (94%) in the physiotherapy the three groups. There were no significant differgroup.
ences between the groups in resource utilisation. Most of the physiotherapy sessions took place in the wait-and-see group reported absenteeism during the 6-week intervention period. However, the from paid labour because of pain in their elbow number of physiotherapy sessions was substantial in during the entire follow-up period of 52 weeks, the injection group, and most of these sessions took compared with 12 patients in the injection group and place after the 6-week intervention period. The six patients in the physiotherapy group. The mean number of visits to GPs and other healthcare provi-differences in absenteeism between the three groups ders was very small for patients in the wait-and-see were mainly caused by a small number of patients in group.
the physiotherapy group (n = 3) and the wait-andsee group (n = 2) who reported long-term absenteeAs was expected, the percentage of patients who ism (more than 50 days). Six patients in the waittook medication was less in the physiotherapy group and-see group reported absenteeism from unpaid compared with the wait-and-see group and patients work, six patients in the injection group and seven in the injection group (16% vs 36% vs 36%, respecpatients in the physiotherapy group. tively). Pain medication was not included as part of the protocol in the physiotherapy intervention. Only Costs a few patients (n = 24) took over-the-counter medication. Table IV shows the mean (SD) per patient costs Only one patient reported having had an x-ray for each intervention group during the follow-up examination. None of the patients had received pro-period. fessional home care. During the trial, only three patients had visited an outpatient department of a Direct Healthcare Costs hospital to undergo surgery for lateral epicondylitis; Direct healthcare costs in the wait-and-see group one patient from the wait-and-see group and two and the physiotherapy group consisted mainly of the patients from the injection group. Only four patients costs of treatment according to the trial protocol. reported a visit to an alternative therapist.
The injection group showed an increase in direct The distance and time spent travelling to the healthcare costs after the 6-week intervention physician and the number of hours of paid help were period. The largest percentage of these additional very low; all patients lived within a one kilometre costs was attributable to physiotherapy, surgery and range of their physician.
medication. At baseline and during the complete follow-up
The mean direct healthcare costs were signifiperiod, 44 (75%) patients in the wait-and-see group, cantly lower in the wait-and-see group, compared 37 (60%) in the injection group and 42 (66%) in the with the physiotherapy group and the injection physiotherapy group were employed. Eight patients group, and were significantly lower in the injection group than in the physiotherapy group. The mean therapy group; the mean indirect costs in the waitdirect healthcare costs in the wait-and-see group and-see group were 15% (€94) lower than in the were 61% (€87) lower than in the injection group, physiotherapy group. The 95% CIs showed that this and 74% (€158) lower than in the physiotherapy difference was statistically significant for the injecgroup.
tion group versus the physiotherapy group and also for the injection group versus the wait-and-see
Direct Non-Healthcare Costs group (see table IV ). The direct non-healthcare costs showed no statistically significant differences between the three Total Costs groups (see table IV ).
The mean total costs per patient for the corticosteroid injection group were €430, compared with
Total Direct Costs
€631 for the wait-and-see policy group and €921 The mean total direct costs in the wait-and-see for the physiotherapy group. Although the total digroup were 58% (€153) lower than in the injection rect costs in the wait-and-see group were lower, group, and 64% (€196) lower than in the physiocompared with the injection group and the physiotherapy group. The differences in total direct costs at therapy group, the total costs in the injection group 52 weeks for the wait-and-see group versus the were the lowest, because of the low indirect costs. injection group and the wait-and-see group versus
The mean total costs in the injection group were the physiotherapy group, respectively, were statisti-53% (€491) lower than in the physiotherapy group, cally significant (see table IV).
a difference which was statistically significant. The
Indirect Costs
mean total costs in the wait-and-see group were 47% Indirect costs contributed substantially to the to-(€201) higher than in the injection group and 31% tal costs of lateral epicondylitis. The indirect costs in (€290) lower than in the physiotherapy group. None the injection group were considerably lower than in of these differences were statistically significant the other two groups. Patients in the physiotherapy (see table IV). group reported more absenteeism from work and were less able to perform their daily household Cost-Effectiveness and Cost-Utility Analyses activities at the end of the trial, whereas the waitand-see group reported more absenteeism at the Incremental cost-effectiveness and cost-utility beginning of the trial. ratios are presented in table V. The cost-effectiveThe mean indirect costs in the injections group ness ratios (general improvement, pain during the were 68% (€354) lower than in the wait-and-see day, disability) indicated that no intervention was group, and 73% (€448) lower than in the physio-dominant (less costly and more effective) over any b Indicating less elbow pain in common situations. I = corticosteroid injections; PT = physiotherapy; WS = wait-and-see policy.
other intervention. The corticosteroid injections cost/effect pairs located in the north-east quadrant were less costly compared with physiotherapy and on the cost-effectiveness planes ranged between the wait-and-see policy, but they were also less 67% and 80% for all outcome measures. effective.
Physiotherapy versus Wait-And-See Policy
For the comparison of physiotherapy and wait-
Physiotherapy versus Corticosteroid Injections
and-see policy, the percentage in the north-east Figure 1 shows the cost-utility plane for the comquadrant varied between 73% and 78% for general parison physiotherapy and corticosteroid injection improvement, pain during the day and elbow disaas an example that most of the incremental cost/ bility. The cost-utility ratio showed 55% of the effect pairs are located in the north-east quadrant incremental cost/utility pairs in the north-east quad-(94%). This indicates that physiotherapy is more rant, 12% in the south-east quadrant, 6% in the effective as well as more costly than corticosteroid injection. For the other outcome measures the percentage of incremental cost/effect pairs located in the north-east quadrant of the cost-effectiveness plane ranged from 94% to 98%.
The acceptability curve (figure 2) shows the probability that physiotherapy is cost effective at a certain ceiling ratio. The higher the ceiling ratio the more likely the treatment, in this case physiotherapy, would be accepted as cost effective. If a treatment costing €20 000 per improvement in outcome is considered cost effective, the probability that physiotherapy will be a cost-effective alternative to corticosteroid injections is approximately 80%.
Corticosteroid Injections versus Wait-And-See Policy
For the wait-and-see policy compared with corticosteroid injections the percentage of incremental group were significantly lower than those in the physiotherapy group and the injection group. The indirect costs were higher in the physiotherapy group and the wait-and-see group than in the injection group. The results of both costs and effects (cost-effectiveness ratio) showed no dominance for any one of the three interventions.
Although corticosteroid injections were significantly less costly, they were significantly less effective than physiotherapy after 52 weeks; the incremental cost-utility ratio for physiotherapy compared with corticosteroid injections was approximately €12 000 per utility gain. Physiotherapy shows somewhat better clinical effects than the wait-andsee policy, while the wait-and-see policy is slightly less costly. The incremental cost-utility ratio for physiotherapy compared with the wait-and-see polisouth-west quadrant and 27% in the north-west cy was more than €34 000 per utility gain. Furtherquadrant. more, the incremental cost/effect pairs on the costIn figure 3 and figure 4 , the efficient frontiers for effectiveness plane were located around zero. general improvement and utility showed that physiTherefore, we concluded that this cost-utility ratio otherapy results in more effect but also more costs should not lead to a firm recommendation in favour compared with wait-and-see policy and corticosterof physiotherapy over a wait-and-see policy. The oid injection.
wait-and-see policy produced slightly better clinical results at an increased cost compared with corticoDiscussion steroid injections, resulting in an incremental costutility ratio of approximately €7000 per utility After the 1-year follow-up, physiotherapy showgained. The sample size calculation to demonstrate a ed more beneficial effects than the wait-and-see difference in the clinical trial might not be enough to policy and corticosteroid injections. However, only prove cost effectiveness, because the variation in the difference between physiotherapy and corticocost data is usually larger compared with clinical steroid injections was statistically significant in favour of physiotherapy.
[11] Comparing the mean total costs of these interventions, a difference was found between corticosteroid injections and physiotherapy in favour of corticosteroid injections. With regard to cost effectiveness, none of the interventions was found to be superior.
The direct healthcare costs and the indirect costs were the main determinants of the total costs. The direct healthcare costs were lower for the wait-andsee policy compared with physiotherapy and corticosteroid injections, and lower for corticosteroid injections than for physiotherapy. The direct nonhealthcare costs were minimal and showed no differences. The total direct costs in the wait-and-see costs and effects showed no dominance, it is difficult to decide whether physiotherapy, corticosteroid injections or a wait-and-see policy is the optimal treatment for lateral epicondylitis. Physiotherapy shows somewhat better clinical effects, while the wait-and-see policy is slightly less costly than physiotherapy but still produces slightly better clinical results than corticosteroid injections. The clinical guidelines for GPs in The Netherlands recommend a wait-and-see policy. [8] The results of this cost-effectiveness analysis provide no reason to update or amend these guidelines. 
